NL300104I2 - Carbapenemen die een carboxy-gesubstitueerde fenylgroep bevatten, werkwijzen voor de bereiding ervan, tussenproducten en gebruik als antibiotica. - Google Patents

Carbapenemen die een carboxy-gesubstitueerde fenylgroep bevatten, werkwijzen voor de bereiding ervan, tussenproducten en gebruik als antibiotica.

Info

Publication number
NL300104I2
NL300104I2 NL300104C NL300104C NL300104I2 NL 300104 I2 NL300104 I2 NL 300104I2 NL 300104 C NL300104 C NL 300104C NL 300104 C NL300104 C NL 300104C NL 300104 I2 NL300104 I2 NL 300104I2
Authority
NL
Netherlands
Prior art keywords
carbapenemes
antibiotics
intermediates
carboxy
preparation
Prior art date
Application number
NL300104C
Other languages
English (en)
Other versions
NL300104I1 (nl
Original Assignee
Astrazeneca Ul Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ul Ltd filed Critical Astrazeneca Ul Ltd
Publication of NL300104I1 publication Critical patent/NL300104I1/nl
Publication of NL300104I2 publication Critical patent/NL300104I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL300104C 1992-02-04 2002-10-18 Carbapenemen die een carboxy-gesubstitueerde fenylgroep bevatten, werkwijzen voor de bereiding ervan, tussenproducten en gebruik als antibiotica. NL300104I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929202298A GB9202298D0 (en) 1992-02-04 1992-02-04 Antibiotic compounds
PCT/GB1993/000217 WO1993015078A1 (en) 1992-02-04 1993-02-02 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics

Publications (2)

Publication Number Publication Date
NL300104I1 NL300104I1 (nl) 2002-12-02
NL300104I2 true NL300104I2 (nl) 2003-02-03

Family

ID=10709764

Family Applications (1)

Application Number Title Priority Date Filing Date
NL300104C NL300104I2 (nl) 1992-02-04 2002-10-18 Carbapenemen die een carboxy-gesubstitueerde fenylgroep bevatten, werkwijzen voor de bereiding ervan, tussenproducten en gebruik als antibiotica.

Country Status (35)

Country Link
US (7) US5478820A (nl)
EP (1) EP0579826B1 (nl)
JP (1) JP2730600B2 (nl)
KR (1) KR100200986B1 (nl)
CN (1) CN1036006C (nl)
AP (1) AP398A (nl)
AT (1) ATE173262T1 (nl)
AU (1) AU668133B2 (nl)
CA (1) CA2106370C (nl)
CZ (1) CZ286878B6 (nl)
DE (2) DE10299041I2 (nl)
DK (1) DK0579826T3 (nl)
ES (1) ES2123654T3 (nl)
FI (1) FI104074B (nl)
GB (2) GB9202298D0 (nl)
GE (1) GEP20022694B (nl)
HK (1) HK1013998A1 (nl)
HR (1) HRP930103B1 (nl)
HU (3) HU213675B (nl)
IL (1) IL104588A (nl)
LU (1) LU90970I2 (nl)
MY (1) MY111685A (nl)
NL (1) NL300104I2 (nl)
NO (2) NO304315B1 (nl)
NZ (2) NZ246917A (nl)
PL (3) PL174936B1 (nl)
RU (1) RU2117659C1 (nl)
SG (1) SG48817A1 (nl)
SI (1) SI9300056B (nl)
SK (1) SK280890B6 (nl)
TW (1) TW408124B (nl)
UA (1) UA44885C2 (nl)
WO (1) WO1993015078A1 (nl)
YU (1) YU48998B (nl)
ZA (1) ZA93453B (nl)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2106330A1 (en) * 1992-10-07 1994-04-08 Patrice J. Siret Antibiotic compounds
US5602118A (en) * 1993-03-16 1997-02-11 American Cyanamid Company 2-thiosubstituted carbapenems
GB9515975D0 (en) * 1995-08-04 1995-10-04 Zeneca Ltd Chemical compounds
UA62920C2 (en) * 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
TW513430B (en) * 1996-07-12 2002-12-11 Merck & Co Inc Process for synthesizing carbapenem antibiotics
EP0923545A1 (en) 1996-08-17 1999-06-23 Zeneca Limited 3-mercaptopyrrolidines as farnesyl protein transferase inhibitors
ATE229962T1 (de) * 1996-10-10 2003-01-15 Merck & Co Inc Verfahren zur herstellung von zwischenprodukten in herstellung von carbapenem-seitenketten
US5877328A (en) * 1996-10-10 1999-03-02 Merck & Co., Inc. Process for synthesizing carbapenem side chain intermediates
CA2268820A1 (en) * 1996-10-28 1998-05-07 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
US6180783B1 (en) 1997-06-16 2001-01-30 Merck & Co., Inc. Stabilized carbapenem intermediates and improved process for carbapenem synthesis
EA001926B1 (ru) * 1997-06-16 2001-10-22 Мерк Энд Ко., Инк. Стабилизированные карбапенемовые полупродукты и их синтетическое применение
JP3378021B2 (ja) * 1997-07-10 2003-02-17 メルク エンド カンパニー インコーポレーテッド 結晶形態の抗菌性側鎖中間体
US5965747A (en) * 1997-07-10 1999-10-12 Merck & Co., Inc. Crystalline forms of antibiotic side chain intermediates
US5872250A (en) * 1997-07-30 1999-02-16 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
JP3953274B2 (ja) * 1998-03-02 2007-08-08 メルク エンド カムパニー インコーポレーテッド カルバペネム抗生物質の合成方法
US6504027B1 (en) 1998-03-02 2003-01-07 Merck & Co., Inc. Decarboxylation process for synthesizing carbapenem antibiotics
EP1104424B1 (en) 1998-06-17 2004-04-07 Merck & Co., Inc. Process for the synthesis of carbapenem intermediates
US6548492B1 (en) 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
US6486150B2 (en) 1999-10-29 2002-11-26 Merck & Co., Inc. Process for formulation of antibiotic compounds
GB9930318D0 (en) * 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
GB9930317D0 (en) * 1999-12-22 2000-02-09 Zeneca Ltd Novel compounds
AR035728A1 (es) * 2001-01-16 2004-07-07 Merck & Co Inc Proceso perfeccionado para la sintesis de carbapenem
EP1442038A4 (en) * 2001-09-26 2005-01-05 Merck & Co Inc CRYSTALLINE FORMS OF CARBAPENEM ANTIBIOTICS AND MANUFACTURING METHOD
WO2003027067A2 (en) * 2001-09-26 2003-04-03 Merck & Co., Inc. Process for making carbapenem compounds
AU2002366444A1 (en) * 2001-11-08 2003-09-09 Merck & Co., Inc. Compounds useful in the treatment of anthrax
JP4625637B2 (ja) 2002-02-22 2011-02-02 シャイア エルエルシー 活性物質送達系及び活性物質を保護し投与する方法
UA76059C2 (en) * 2002-05-29 2006-06-15 Merck & Co Inc Compounds used for treating anthrax or inhibiting lethal factor
EP1747550A2 (en) * 2004-05-07 2007-01-31 Infinium Labs, Inc. Multi-position multi-level user interface system
CA2566191A1 (en) * 2004-05-11 2005-12-15 Merck & Co., Inc. Process for making n-sulfonated-amino acid derivatives
US20100003276A1 (en) * 2004-12-07 2010-01-07 Hermes Jeffery D Methods for treating anthrax and inhibiting lethal factor
CN100344613C (zh) * 2005-10-20 2007-10-24 上海交通大学 (2s,4s)－1－(4－硝基苄氧羰基)－2－[(3－烯丙氧羰基)－苯基氨基甲酰基]－吡咯烷－4－基硫醇的制备方法
EP2308874B1 (en) * 2005-12-07 2013-01-23 Basilea Pharmaceutica AG Bridged monobactams useful as beta-lactamase inhibitors
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
US8293894B2 (en) * 2006-11-20 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
CN101357916B (zh) * 2007-06-22 2010-12-15 山东轩竹医药科技有限公司 含有二氢咪唑甲酰胺基的培南化合物
CN101367807B (zh) * 2007-06-28 2011-01-12 山东轩竹医药科技有限公司 被巯基吡咯烷甲酰胺基吡啶取代的培南衍生物
CN101367815B (zh) * 2007-06-28 2012-07-04 山东轩竹医药科技有限公司 六元环甲酰胺取代的巯基吡咯烷碳青霉烯化合物
CN101362760B (zh) * 2007-08-07 2010-12-15 山东轩竹医药科技有限公司 1β-甲基碳代青霉烯化合物
CN101362761B (zh) * 2007-08-12 2011-05-18 山东轩竹医药科技有限公司 含有巯基哌啶的碳代青霉烯抗生素
CN101412720B (zh) * 2007-08-27 2011-05-18 山东轩竹医药科技有限公司 含有巯基氮杂环乙烯基的碳青霉烯化合物
CN101376641B (zh) * 2007-08-28 2010-12-08 上海医药工业研究院 碳青霉烯类青霉素厄他培南的中间体及其制备方法和应用
WO2009150630A2 (en) 2008-06-11 2009-12-17 Ranbaxy Laboratories Limited Process for preparing a carbapenem antibiotic composition
EP2326648B1 (en) * 2008-07-30 2012-09-19 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
KR20110058887A (ko) * 2008-09-18 2011-06-01 마누 차우드하리 신규한 단일 유닛 카바페넴 아미노글라이코사이드 제형
US9388184B2 (en) 2009-04-30 2016-07-12 Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. Intermediate of Ertapenem, a composition comprising the same and preparation methods thereof
WO2011048583A1 (en) 2009-10-23 2011-04-28 Ranbaxy Laboratories Limited Process for the preparation of carbapenem compounds
US8729260B2 (en) 2010-05-19 2014-05-20 Savior Lifetec Corporation Process for the preparation of carbapenem using cabapenem intermediates and recovery of cabapenem
CN102558182B (zh) * 2010-12-31 2015-02-11 石药集团中奇制药技术（石家庄）有限公司 一种厄他培南钠晶型及其制备方法
US8691803B2 (en) 2011-01-24 2014-04-08 Savior Lifetec Corporation Process for the preparation of antibiotic compounds
WO2013121279A2 (en) * 2012-02-14 2013-08-22 Aurobindo Pharma Limited Process to prepare ertapenem
KR20150065176A (ko) 2012-10-12 2015-06-12 산도즈 아게 에르타페넴 중간체의 제조법
EP2968274B1 (en) 2013-03-15 2019-10-16 Kala Pharmaceuticals, Inc. Meropenem derivatives and uses thereof
IN2013MU03862A (nl) 2013-12-11 2015-07-31 Unimark Remedies Ltd
AU2017235293B2 (en) * 2016-03-16 2021-02-04 Merck Sharp & Dohme Corp. Carbapenem compounds
CN106565579A (zh) * 2016-06-26 2017-04-19 宁夏海诚电化信息科技有限公司 一种尔它培南侧链生产工艺
CN110698480B (zh) * 2018-07-09 2023-09-08 武汉启瑞药业有限公司 一种厄他培南中间体的合成及纯化方法
KR20210117301A (ko) * 2019-01-23 2021-09-28 글리코리시스 바이오메드 컴퍼니 리미티드 글루코스 대사 장애의 지속성 예방 또는 치료에 사용하기 위한 베타-락탐 화합물 또는 이의 염

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218462A (en) * 1978-10-24 1980-08-19 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1-substituted-1-carbade-thiapen-2-em-3-carboxylic acids
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4206219A (en) * 1978-10-24 1980-06-03 Merck & Co., Inc. 6- and 1-Substituted-1-carbadethiapen-2-em-3-carboxylic acid
US4208422A (en) * 1978-10-24 1980-06-17 Merck & Co., Inc. 1-Substituted-pen-2-em-3-carboxylic acids
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
JPS60233076A (ja) * 1984-05-03 1985-11-19 Sumitomo Chem Co Ltd 新規なβ−ラクタム化合物およびその製造法
EP0182213B1 (en) * 1984-11-08 1990-09-26 Sumitomo Pharmaceuticals Company, Limited Carbapenem compounds and production thereof
FI81576C (fi) * 1984-12-25 1990-11-12 Sankyo Co Foerfarande foer framstaellning av derivat av 6-(1-hydroxietyl)-2-(1,2-disubstituerade-4-pyrrolidinyltio)-2- karbapenem-3-karboxylsyra, vilka aer anvaendbara som laekemedel.
DE3780344T2 (de) * 1986-03-27 1993-01-28 Sumitomo Pharma Beta-lactam-verbindungen und deren herstellung.
US4974544A (en) * 1986-10-07 1990-12-04 Ricoh Company, Co. Vapor deposition apparatus
US4963544A (en) * 1988-05-23 1990-10-16 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US5194624A (en) * 1988-05-23 1993-03-16 Fujisawa Pharmaceutical Co., Ltd. Intermediates for the preparation of compounds of antimicrobial activity
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
NZ237191A (en) * 1990-02-23 1992-12-23 Sankyo Co 2-((substituted amide) substituted heterocyclylthio) carbpen-2-em derivatives and pharmaceutical compositions
US5554606A (en) * 1990-03-12 1996-09-10 Zeneca Limited Antibiotic compounds
AU644008B2 (en) * 1990-08-10 1993-12-02 Sumitomo Pharmaceuticals Company, Limited Beta-lactam compounds, and their production and use
GB9107341D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
GB9107342D0 (en) * 1991-04-08 1991-05-22 Ici Plc Antibiotic compounds
FI101226B1 (fi) * 1991-06-04 1998-05-15 Sankyo Co Menetelmä lääkeaineena käyttökelpoisten 2-[2-(karbonyyli)pyrrolidin-4-yylitio]-6-(1-hydroksietyyli)-1-metyylikarbapen-2-eemi-3-karboksyylihappojohdannaisten valmistamiseksi
ZA929008B (en) * 1991-12-13 1993-05-21 Bristol Myers Squibb Co Piperazinyl- and piperidinyl-cyclohexanols.
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds
CA2091309A1 (en) * 1992-03-26 1993-09-27 Frederic H. Jung Antibiotic compounds
GB9304156D0 (en) * 1992-03-26 1993-04-21 Zeneca Ltd Antibiotic compounds
CA2099817A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099811A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2099818A1 (en) * 1992-07-21 1994-01-22 Frederic H. Jung Antibiotic compounds
CA2106141A1 (en) * 1992-09-28 1994-03-29 Michael J. Betts Antibiotic compounds

Also Published As

Publication number Publication date
GEP20022694B (en) 2002-05-10
NO2002010I2 (no) 2005-03-11
DE69322007D1 (de) 1998-12-17
TW408124B (en) 2000-10-11
US7342005B2 (en) 2008-03-11
GB9300456D0 (en) 1993-03-03
NZ272038A (en) 1997-07-27
NO304315B1 (no) 1998-11-30
JPH06506704A (ja) 1994-07-28
ATE173262T1 (de) 1998-11-15
NO933530L (no) 1993-10-04
CN1079224A (zh) 1993-12-08
EP0579826B1 (en) 1998-11-11
DK0579826T3 (da) 1999-07-26
HU211840A9 (en) 1995-12-28
IL104588A (en) 1999-03-12
DE10299041I1 (de) 2003-02-20
AU3457493A (en) 1993-09-01
SK280890B6 (sk) 2000-09-12
WO1993015078A1 (en) 1993-08-05
FI104074B1 (fi) 1999-11-15
AP9300480A0 (en) 1993-01-31
MY111685A (en) 2000-11-30
YU5493A (sh) 1996-05-20
HUT64764A (en) 1994-02-28
NO933530D0 (no) 1993-10-01
LU90970I2 (fr) 2002-12-09
US20050209212A1 (en) 2005-09-22
US5856321A (en) 1999-01-05
RU2117659C1 (ru) 1998-08-20
US5478820A (en) 1995-12-26
HRP930103A2 (en) 1994-12-31
US6187804B1 (en) 2001-02-13
SI9300056A (en) 1993-09-30
FI104074B (fi) 1999-11-15
EP0579826A1 (en) 1994-01-26
PL174649B1 (pl) 1998-08-31
HU9302777D0 (en) 1993-12-28
NO2002010I1 (no) 2002-10-09
CN1036006C (zh) 1997-10-01
US6521612B2 (en) 2003-02-18
HU213675B (en) 1997-09-29
UA44885C2 (uk) 2002-03-15
FI930474A0 (fi) 1993-02-03
GB9202298D0 (en) 1992-03-18
ES2123654T3 (es) 1999-01-16
CZ286878B6 (en) 2000-07-12
SI9300056B (sl) 2000-02-29
IL104588A0 (en) 1993-06-10
US20020042408A1 (en) 2002-04-11
NZ246917A (en) 1995-09-26
HUT66514A (en) 1994-12-28
US5652233A (en) 1997-07-29
KR100200986B1 (ko) 1999-06-15
DE69322007T2 (de) 1999-04-01
CA2106370A1 (en) 1993-08-05
PL174936B1 (pl) 1998-10-30
CZ206793A3 (en) 1994-04-13
JP2730600B2 (ja) 1998-03-25
CA2106370C (en) 2003-11-25
NL300104I1 (nl) 2002-12-02
DE10299041I2 (de) 2003-06-12
US7041836B2 (en) 2006-05-09
ZA93453B (en) 1993-08-05
PL174601B1 (pl) 1998-08-31
SG48817A1 (en) 1998-05-18
HK1013998A1 (en) 1999-09-17
YU48998B (sh) 2003-04-30
HRP930103B1 (en) 1999-12-31
SK106393A3 (en) 1994-04-06
AP398A (en) 1995-08-29
FI930474A (fi) 1993-08-05
AU668133B2 (en) 1996-04-26
US20030144264A1 (en) 2003-07-31

Similar Documents

Publication Publication Date Title
NL300104I2 (nl) Carbapenemen die een carboxy-gesubstitueerde fenylgroep bevatten, werkwijzen voor de bereiding ervan, tussenproducten en gebruik als antibiotica.
NL300077I1 (nl) Erythromycineverbindingen, werkwijze voor hun bereiding en hun toepassing als geneesmiddel.
NO904637L (no) Antiballistiske materialer.
NO912799L (no) Foradditiver for droevtyggere.
TR199600096A2 (tr) Yeni bilesikler.
FI935497A0 (fi) Saekerhetsventil foer hoegtryckspumpar, hoegtryckvattenstraolemaskiner e.d.
FI932649A (fi) Bifenylderivat, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning
FI905700A (fi) Heterocykliska foereningar, deras framstaellning och dessa innehaollande laekemedel.
IT1246733B (it) Complesso di rulli di precompressione di laminati.
FR2690989B1 (fr) Codeur annulaire composite.
NL193196B (nl) Bouwelement voor een systeemvloer.
FI931599A0 (fi) Bensimidazoler, dessa foereningar innehaollande laekemedel och foerfarandefoer deras framstaellning
NL1004593A1 (nl) Werkwijze voor de bereiding van een gedeutereerde verbinding.
TR27321A (tr) Insektisidal terkip.
TR26907A (tr) Yeni poliiodine bilesikleri, hazirlik prosesi ve bunlari iceren kontrast maddesi.
ITMI932710A0 (it) Dispositivo per la lavorazione di un anello conico, in particolare di un anello di attrito.
TR199601018A1 (tr) Farmasötik bilesikler.
KR920000835U (ko) 화장실 등에 사용되는 부스 (Booth)
NL192383B (nl) Transportsamenstel zoals voor personen, alsmede overbruggingsinrichting hierbij.
ITGE930040A1 (it) Dispositivo di filatura ad anello.
NO952426D0 (no) Nytt legemiddel som inneholder 3,7-diazabisyklo[3,3,1Ånonan forbindelser
FI934317A0 (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
IT1276784B1 (it) Anello distaccatore
FI910906A (fi) Maskin och method foer sortering av tunna spaon, stickor och oevertjocka traespaon.
ITRM920104U1 (it) Complesso ad anello per chiavi.